JP2010506147A5 - - Google Patents

Download PDF

Info

Publication number
JP2010506147A5
JP2010506147A5 JP2009529589A JP2009529589A JP2010506147A5 JP 2010506147 A5 JP2010506147 A5 JP 2010506147A5 JP 2009529589 A JP2009529589 A JP 2009529589A JP 2009529589 A JP2009529589 A JP 2009529589A JP 2010506147 A5 JP2010506147 A5 JP 2010506147A5
Authority
JP
Japan
Prior art keywords
risk
disease progression
concentration
crp
correlating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009529589A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010506147A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/008313 external-priority patent/WO2008037420A1/en
Publication of JP2010506147A publication Critical patent/JP2010506147A/ja
Publication of JP2010506147A5 publication Critical patent/JP2010506147A5/ja
Pending legal-status Critical Current

Links

JP2009529589A 2006-09-29 2007-09-25 関節リウマチを有する患者のための疾患進行のリスク評価 Pending JP2010506147A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06020645 2006-09-29
EP06021887 2006-10-19
PCT/EP2007/008313 WO2008037420A1 (en) 2006-09-29 2007-09-25 Assessing the risk of disease progression for a patient with rheumatoid arthritis

Publications (2)

Publication Number Publication Date
JP2010506147A JP2010506147A (ja) 2010-02-25
JP2010506147A5 true JP2010506147A5 (enExample) 2010-07-15

Family

ID=38859738

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009529589A Pending JP2010506147A (ja) 2006-09-29 2007-09-25 関節リウマチを有する患者のための疾患進行のリスク評価

Country Status (6)

Country Link
US (1) US8058013B2 (enExample)
EP (1) EP2074428B1 (enExample)
JP (1) JP2010506147A (enExample)
CA (1) CA2663730A1 (enExample)
ES (1) ES2545688T3 (enExample)
WO (1) WO2008037420A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010038104A1 (en) * 2008-10-03 2010-04-08 INSERM (Institut National de la Santé et de la Recherche Médicale) Combination of cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event.
WO2011047358A1 (en) 2009-10-15 2011-04-21 Crescendo Bioscience Biomarkers and methods for measuring and monitoring inflammatory disease activity
US20130246097A1 (en) * 2010-03-17 2013-09-19 Howard M. Kenney Medical Information Systems and Medical Data Processing Methods
JP5786020B2 (ja) 2010-04-16 2015-09-30 アボットジャパン株式会社 関節リウマチを診断する方法および試薬
US8883427B2 (en) 2010-06-30 2014-11-11 New York University Quantifying local inflammatory activity and its use to predict disease progression and tailor treatments
JP5924659B2 (ja) * 2010-10-14 2016-05-25 国立大学法人 長崎大学 免疫複合体の網羅的解析方法および新規関節リウマチバイオマーカー
US20140142861A1 (en) * 2010-11-06 2014-05-22 Oklahoma Medical Research Foundation Biomarkers For Predicting Progressive Joint Damage
US11531033B2 (en) * 2013-03-15 2022-12-20 Exagen Inc. Methods for treating and diagnosing systemic lupus erythematosus
JP2015061592A (ja) * 2013-08-21 2015-04-02 コニカミノルタ株式会社 超音波診断装置、超音波画像処理方法およびコンピュータ読み取り可能な非一時的な記録媒体
CA2943821A1 (en) 2014-04-02 2015-10-08 Crescendo Bioscience Biomarkers and methods for measuring and monitoring juvenile idiopathic arthritis activity
EP3155439A4 (en) 2014-06-10 2018-03-14 Crescendo Bioscience Biomarkers and methods for measuring and monitoring axial spondyloarthritis disease activity
CA3207751A1 (en) 2015-09-29 2017-04-06 Laboratory Corporation Of America Holdings Biomarkers and methods for assessing psoriatic arthritis disease activity
WO2017058999A2 (en) 2015-09-29 2017-04-06 Crescendo Bioscience Biomarkers and methods for assessing response to inflammatory disease therapy withdrawal
GB201603571D0 (en) * 2016-03-01 2016-04-13 Univ Warwick Markers for skeletal disorders
WO2021087116A1 (en) * 2019-10-30 2021-05-06 Cd Diagnostics, Inc. Biomarkers of early osteoarthritis
CN114089632B (zh) * 2021-11-15 2023-08-18 陕西师范大学 基于模糊逻辑的风湿免疫疾病特征识别方法及系统

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9105893D0 (en) * 1991-03-20 1991-05-08 Orion Yhtymae Oy Bone resorption assay based on a peptide liberated during collagen degradation
US5888510A (en) * 1993-07-21 1999-03-30 Chugai Seiyaku Kabushiki Kaisha Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component
AU3746295A (en) * 1994-10-17 1996-05-06 Osteometer Biotech As Estimation of the fragmentation pattern of collagen in body fluids and the diagnosis of disorders associated with the metabolism of collagen
FR2752842B1 (fr) 1996-08-30 1998-11-06 Biomerieux Sa Antigenes derives des filaggrines et leur utilisation pour le diagnostic de la polyarthrite rhumatoide
NL1004539C2 (nl) 1996-11-15 1998-05-20 Stichting Tech Wetenschapp Peptide afgeleid van een door auto-antilichamen van patiënten met reumatoïde artritis herkend antigeen, antilichaam daartegen en werkwijze voor het detecteren van auto-immuunantilichamen.
CA2309534A1 (en) 1997-11-28 1999-06-10 Innogenetics N.V. Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment
FR2773157B1 (fr) 1997-12-30 2001-10-05 Bio Merieux Epitopes peptidiques reconnus par des auto-anticorps antifilaggrine presents dans le serum des patients atteints de polyarthrite rhumatoide
IL136889A0 (en) * 1998-01-09 2001-06-14 Pfizer Matrix metalloprotease inhibitors
EP1240180A2 (en) 1999-12-21 2002-09-18 Innogenetics N.V. Peptides designed for the diagnosis and treatment of rheumatoid arthritis
NL1019540C2 (nl) 2001-12-11 2003-07-01 Stichting Tech Wetenschapp Werkwijze voor het detecteren van auto-antilichamen van patienten die lijden aan reumatoïde artritis, peptide en assaykit.
CA2552425C (en) * 2004-02-27 2018-02-06 F. Hoffmann-La Roche Ag Method of assessing rheumatoid arthritis by measuring rheumatoid factor and interleukin-6
US20060063162A1 (en) * 2004-09-23 2006-03-23 Deng David X Biological marker for inflammation
WO2006098401A1 (ja) * 2005-03-16 2006-09-21 The University Of Tokushima 関節リウマチ罹患リスクの測定方法
US7713521B2 (en) * 2005-08-12 2010-05-11 Schering Corporation MCP1 fusions

Similar Documents

Publication Publication Date Title
JP2010506147A5 (enExample)
EP2491860A3 (en) Analyte monitoring
EP1707017A4 (en) METHOD AND DEVICE FOR JITTER MEASUREMENT
EP2891885A3 (en) Diabetes-related biomarkers and methods of use thereof
DE602005017308D1 (de) Untersuchungsapparat mit Ultraschallsonde, Ultraschalluntersuchungsgerät und Untersuchungsmethode mit einer Ultraschallsonde
DK2006680T3 (da) Indikator og fremgangsmåde til måling af biologisk belastning
EP1939596A4 (en) SENSOR AND EXTERNAL TURBULENCE MEASURING PROCESS WITH THIS
HUE058823T2 (hu) Rendszer és eljárás elektrokémiai analitérzékelõ mûködtetésére
EP2118653A4 (en) MATERIALS AND METHOD FOR EFFICIENT AND ACCURATE DETECTION OF ANALYTES
BRPI0814320A2 (pt) Método para determinar automaticamente o estado de uso de um dispositivo médico eletrônico e/ou ativar dito dispositivo médico eletrônico, e, estetoscópio eletrônico.
DE602004026239D1 (de) Vorrichtung zur Messung der Herzfrequenz und deren Fertigungs- sowie Messverfahren
EP2008100A4 (en) ESTABLISHING ANTIBODY PROFILES FOR DETERMINING PATIENT SENSITIVITY TO TREATMENT
JP2009524829A5 (enExample)
EP2037272A4 (en) KIT AND METHOD FOR DETECTING OR BZW. FOR QUANTIFYING AN ANALYTE
EP1714146A4 (en) METHOD FOR MEASURING CORE-CONTAINING RED BLOOD CELLS
BRPI0821397A2 (pt) uso de um material calibrador, método para calibrar um imunoensaio para a detecção de auto-anticorpos, série de padrões de calibração, kit de imunoensaio, e método para quantificar a quantidade de proteina ligada a uma superficie sólida
EP1985991A4 (en) MEASURING PROBE, DEVICE AND METHOD FOR SURFACE MEASUREMENT OF A SAMPLE
EP2120033A4 (en) SAMPLING METHOD AND METHOD FOR ESTIMATING A BLADE TEMPERATURE
JP2007508527A5 (enExample)
EP2238431A4 (en) DEVELOPMENT AND USE OF CYSTEIN-MARKED FLUORESCENT PROBLEMS FROM UNBUNDLED ANALYTES
EP1950565A4 (en) METHOD FOR TESTING ANTIGEN AND THE KIT USED THEREOF
EP1777892A4 (en) RECEIVER DEVICE AND METHOD FOR RELEASING YOUR MEMORY
IL184568A0 (en) Measuring member and device for determining the blood flow of the gastrointestinal tract, as well as for registrating the intestinal peristalsis
JP2010526995A5 (enExample)
FI20055150L (fi) Sakeuden muuttaminen ja mittaaminen